CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Transcranial LED Therapy (Participants ages 9-17) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03724552
NCT03724552N/ACompleted
CompareCT.gov

Evaluation of LED Therapeutic Effect in Youth and Adults With Autism Spectrum Disorder: An Open-Label Pilot Study of a Novel Approach

Massachusetts General Hospital·interventional·Posted Oct 30, 2018·Updated Jul 11, 2024

In Brief

A clinical study evaluating Transcranial LED Therapy (Participants ages 9-17) and Transcranial LED Therapy (Participants ages 18-59) for Autism and Autism Spectrum Disorder. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this 8-week open-label study is to assess the tolerability, safety, and efficacy of Transcranial LED Therapy in patients with Autism Spectrum Disorder (ASD). The investigators propose to enroll up to 30 subjects of both genders ages 9-59 years with intact intellectual functions who meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for Autism Spectrum Disorder (ASD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism, Autism Spectrum Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 30, 2018
Enrollment StartApr 13, 2017
Primary CompletionNov 25, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 7.7 years ago

Interventions

Transcranial LED Therapy (Participants ages 9-17)device

Transcranial Laser Emitting Diode (LED) Therapy (TLT) is a noninvasive intervention in which near-infrared light (830nm-850nm) is applied to forebrain.

Transcranial LED Therapy (Participants ages 18-59)device

Transcranial Laser Emitting Diode (LED) Therapy (TLT) is a noninvasive intervention in which near-infrared light (830nm-850nm) is applied to forebrain.